ArticleFrontiers in psychiatry2026
Auricular acupuncture for insomnia in female patients with non-metastatic breast cancer: study protocol for a multicenter, randomized, controlled clinical trial.
Article in Frontiers in psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Breast cancer patients are at an increased risk of insomnia, which can lead to emotional disorders, reduced quality of life, and potentially higher cancer mortality. Auricular acupuncture (AA) offers a feasible treatment option due to its short procedure time, low technical complexity, and relative safety. However, while preliminary studies suggest potential benefits of AA for treating insomnia, the evidence for the population of breast cancer patients remains insufficient. Methods: This study employs a multicenter single-blind, randomized, controlled trial. A total of 324 patients will be randomly assigned in a 1:1 ratio to either the AA group (n=162) or the nonspecific AA group (NAA) (n=162). Both groups will undergo a 4-week treatment period, with three daily sessions. Follow-up assessments will be conducted at weeks 8 and 16. The primary outcome is the treatment response rate at week 4, and secondary outcomes include the treatment remission rate, the treatment response rate at weeks 8 and 16, change in Insomnia Severity Index (ISI) score, sleep diary, Generalized Anxiety Disorder-7 (GAD-7), Patient Health Questionnaire-9 (PHQ-9), Quality of Life Questionnaire-Core 30 (QLQ-C30), and emergency medication usage. Data will be collected at baseline (week 0), during the intervention (week 2), post-treatment (week 4), and at follow-up (weeks 8 and 16). Discussion: This study represents an initial effort to develop a comprehensive standard operating procedure (SOP) that includes graphic and video instructions for auricular point location and manipulation techniques. It also provides online guidance to instruct patients on how to self-administer AA at home. The aim of the study is to evaluate the clinical efficacy and safety of AA in treating insomnia among female patients with non-metastatic breast cancer. The findings will provide new insights into the promotion of AA for managing breast cancer-related insomnia in a home-use setting, a method that has the potential to conserve medical resources and alleviate economic burdens. Trial registration: https://itmctr.ccebtcm.org.cn/mgt/project/view/-7546531521559384755, identifier ITMCTR2025001101.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.